Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Total 13F shares
-
36,199,999
-
Share change
-
-1,704,991
-
Total reported value
-
$166,471,159
-
Put/Call ratio
-
56%
-
Price per share
-
$4.60
-
Number of holders
-
133
-
Value change
-
-$8,903,915
-
Number of buys
-
58
-
Number of sells
-
61
Institutional Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q4 2021
As of 31 Dec 2021,
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,199,999 shares.
The largest 10 holders included
ArrowMark Colorado Holdings LLC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, Park West Asset Management LLC, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, TWO SIGMA INVESTMENTS, LP, TWO SIGMA ADVISERS, LP, and NORTHERN TRUST CORP.
This page lists
133
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.